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Abstract 
Background: Diabetes, hyperglycemia, and their complications are a growing problem in Brazil. However, no com‑
prehensive picture of this disease burden has yet been presented to date.
Methods: We used Global Burden of Disease 2015 data to characterize diabetes prevalence, incidence and risk fac‑
tors from 1990 to 2015 in Brazil. Additionally, we provide mortality, years of life lost prematurely (YLL), years of life lived 
with disability (YLD) and disability‑adjusted life years (DALYs) lost due to diabetes, as well as similar data for chronic 
kidney disease (CKD) due to diabetes and, as an overall summary measure, for hyperglycemia, the latter expressed as 
high fasting plasma glucose (HFPG).
Results: From 1990 to 2015 diabetes prevalence rose from around 3.6 to 6.1%, and YLLs, YLDs, and DALYs attributable 
to diabetes increased steadily. The crude diabetes death rate increased 90% while that of CKD due to diabetes more 
than doubled. In 2015, HFPG became Brazil’s 4th leading cause of disability, responsible for 65% of CKD, for 7.0% of 
all disability and for the staggering annual loss of 4,049,510 DALYs. Diabetes DALYs increased by 118.6% during the 
period, increasing 42% due to growth in Brazil´s population, 72.1% due to population ageing, and 4.6% due to the 
change in the underlying, age‑standardized rate of DALY due to diabetes. Main risk factors for diabetes were high 
body mass index; a series of dietary factors, most notably low intake of whole grains and of nuts and seeds, and high 
intake of processed meats; low physical activity and tobacco use, in that order.
Conclusions: Our study demonstrates that diabetes, CKD due to diabetes, and hyperglycemia produce a large and 
increasing burden in Brazil. These findings call for renewed efforts to control the joint epidemics of obesity and diabe‑
tes, and to develop strategies to deal with the ever‑increasing burden resulting from these diseases.
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Background
The United Nations and the World Health Organiza-
tion have declared that the non-communicable diseases 
(NCDs) are the current main threat to the health of the 
world’s populations [1, 2], and have identified diabetes 
mellitus as one of the four main NCDs meriting atten-
tion. The majority of this burden now falls on low and 
middle-income countries (LMICs), a result of the fact 
that these countries, which house most of the world’s 
population, have witnessed dramatic rises in both the 
incidence and prevalence of diabetes over recent decades 
[3].
Yet the characterization of the extent and size of the 
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hampered for several reasons. Though diabetes can 
directly cause death and disability, most of its burden is 
distributed across its complications, most notably cardio-
vascular disease, requiring complex approaches to sum 
the damage. Additionally, national databases for disease 
incidence, prevalence, morbidity, including hospitaliza-
tion, and mortality are incipient and incomplete in most 
LMICs.
Since its 2010 reports, the Global Burden of Disease 
Project has assumed an expanded international role in 
characterizing the frequency, risk factors, morbidity 
and mortality of diseases in countries around the world. 
Though estimates are frequently derived by modeling 
when data is missing, the GBD offers LMIC countries 
valuable information on their disease burden.
Brazil is a middle income country with a strong national 
health system [4]. It has to date engaged energetically in 
the WHO’s challenge to confront the NCD challenge [5], 
and over the past decade has improved its national health 
databases and implemented a series of surveys aimed to 
better assess NCD risk factors, prevalence and disease 
burden. The GBD 2015 has incorporated this more pre-
cise information into their internationally standardized 
approach to characterizing disease burden.
The objective of this report is to describe the current 
status and trends of the burden due to diabetes, to CKD 
due to diabetes, and to hyperglycemia in Brazil based on 
GBD 2015 project analyses.
Methods
GBD 2015 includes an annual assessment covering 195 
countries and territories from 1990 to present. It cov-
ers 310 diseases and injuries, 2619 sequelae, and 79 risk 
factors by age and sex. Detailed descriptions of method-
ology and approach of GBD 2015 have been published 
elsewhere [6–9]. We generated the estimates presented 
here with the Institute for Health Metrics and Evaluation 
GBD 2015 visualizations [10, 11].
The GBD 2015 framework recognizes diabetes as both 
a disease, with its proper outcomes, and as one of multi-
ple causes of a series of other diseases. This latter expres-
sion of its pathology is accounted for within the risk 
factor category of high fasting plasma glucose (HFPG), 
which also encompasses the effects of lower levels of 
hyperglycemia. Figure  1 shows this combined burden 
approach. Within it, part of burden is ascribed directly to 
diabetes—defined through ICD-10 codes E10-13, except 
“0.2” codes, related to renal disease—and includes that 
due to living with diabetes (“uncomplicated diabetes”) 
and to its traditional, “microvascular” complications 
(vision loss, including severe low vision and blindness; 
neuropathy; and amputation) [12]. This direct burden is 
shown in the part of the Figure highlighted by the dotted 
red line [6]. The rest of the burden, which results from 
the other recognized complications of both diabetes and 
HFPG [13]—ischemic heart disease, ischemic stroke, 
hemorrhagic stroke, CKD (sub-categorized as being due 
Fig. 1 Dimensions of assessment of burden of diabetes and high fasting plasma glucose, and burden attributable to its risk factors in the Global 
Burden of Disease 2015 (GBD 2015 study)
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to hypertension, glomerulonephritis, diabetes and other 
causes) and tuberculosis [7]—is accounted for through 
HFPG. In these latter calculations, the theoretical mini-
mum risk exposure level of glucose was taken to be 4.8–
5.4 mmol/L (86.4–97.2 mg/dL).
The GBD uses three main indicators to calculate dis-
ease burden—years of life lost due to premature mor-
tality (YLLs), years of life lived with disability (YLDs), 
and the sum of the two—disability-adjusted life years 
(DALYs). Briefly, YLLs are calculated multiplying the 
number of deaths from diabetes or due to HFPG in each 
age group by the reference life expectancy at the average 
age of death for those who die in that age group [8]. YLDs 
were obtained by aggregating diabetes sequelae preva-
lences times their disability weights in age-, sex- and 
year-specific strata [13]. Disability weights were derived 
from population-based surveys of the general public [12]. 
All results are standardized to the world population [8].
To help understand the drivers of change in the number 
of DALYs due to diabetes over the period studied, follow-
ing methodology previously used in the GBD project [9], 
we estimated percent changes due specifically to growth 
in total population, population ageing, and change in 
DALY rates. Each of these three differences is presented 
in absolute number of DALYs and as the relative percent-
age change with reference to the 1990 baseline estimate 
of total DALYs.
GBD 2015 identified through analysis of systematic 
reviews the diabetes risk factors of high body mass index; 
low physical activity; diets low in whole grains, nut and 
seeds, and fruits, and high in red and processed meat and 
in sweetened beverages; absence of alcohol consumption; 
and smoking, the latter using a time lag. The fraction of 
the diabetes burden attributable to each was calculated as 
previously described [7].
This study required no approval by a research ethics 
committee, as it utilized only secondary databases which 
are publicly available, while obeying the ethical princi-





Figure  2 shows the prevalence (right panel) and inci-
dence (left panel) of diabetes from 1990 to 2015, over-
all and separately for women and men. The prevalence 
rose 69% during this period, increasing from 3.6% (95% 
UI 3.3–3.8%) to 6.1% (95% UI 5.6–6.7%). The current 
prevalence is quite similar to that which GBD estimated 
worldwide—6.2% [11]. In 2015 approximately 12 million 
Brazilians had diabetes, this number growing from 2010 
to 2015 by approximately 450,000 cases per year. The esti-
mated annual incidence increased 75% over the period to 
a current rate of 0.63% per year. Of note, much of both 
of these increases in Brazil is due to population aging, 
as age-standardized prevalence and incidence rates have 
increased less—17 and 49%, respectively.
Burden
A total of 62,466 diabetes deaths (95% UI 59,421–65,474) 
occurred in 2015 in Brazil, 56.1% of them being women. 
This percentage was somewhat higher than the percent 
seen globally (50.9%) for women [6]. The crude diabetes 
death rate increased 90% over the period, from 15.8 (95% 
UI 15.4–16.3) per 100,000 in 1990 to 30.1 (95% UI 28.6–
31.5) per 100,000 in 2015 (Additional file  1: Table  S1). 
The increase in the age-standardized diabetes mortality 
in Brazil was much less, 4.4%, from 35.9 (34.8–37.0) to 
37.5 (35.6–39.3) per 100,000.
Fig. 2 GBD 2015 estimated crude incidence (left panel) and prevalence (right panel) of diabetes in Brazil, from 1990 to 2015, standardized to the 
world population. Blue line—females, green line—males, orange line—both sexes
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There were 1152,332 YLLs (95% UI 1,094,056–
1,206,757) due to diabetes in 2015, up 100% from the 
574,910 YLLs (95% UI 558,550–593,148) in 1990. In 
2015, the age-standardized YLLs rate for men was 666.7 
(95% UI 622.3–709.3) per 100,000, up 3.1% from the 
1990 rate of 646.7 (95% UI 619.3–676.3) per 100,000. 
For women, the rate was 588.0 (95% UI 550.9–625.0) per 
100,000, down 17.8% from the 1990 rate of 714.9 (95% UI 
685.9–747.4) per 100,000.
The total number of YLDs due to diabetes in Bra-
zil more than doubled over the period, from 390,624 in 
1990 (95% UI 269,754–39,490) to 957,912 in 2015 (95% 
UI 657,795–1,313,735). YLDs expanded to be responsible 
for 45.4% (36.6–53.1%) of all diabetes DALYs in 2015, up 
from 40.5% (32.1–48.4%) in 1990, a relative increase of 
12%.
The crude rate of DALYs attributable to diabetes 
increased 58.3% over the period, from 641 DALYs (95% 
UI 558–741) per 100,000 in 1990 to 1015 DALYs (95% 
UI 865–1191) per 100,000 in 2015. In comparison, crude 
rate of DALYs for all diseases decreased 20.5% and the 
crude rate of DALYs for all other non-communica-
ble diseases increased only 3.6% in Brazil. When age-
standardized, the rate of DALYs attributable to diabetes 
increased by only 1% from 1990 to 2015. Table 1 shows 
DALY rates for diabetes for Brazil and for the world. The 
age-standardized DALY rates of diabetes in Brazil were 
1.42 and 1.19 times of the world rates in 1990 and 2015, 
respectively.
As shown in Table  2, population growth accounted 
for an increase of 41.9%, aging of the population for an 
increase of 72.1%, and change in the underlying age- and 
sex-standardized rates of DALYs for an increase of 4.6% 
in the absolute number of DALYs due specifically to dia-
betes over the period.
Figure  3 compares age-standardized rates of deaths 
due to diabetes across countries in the Latin Ameri-
can and Caribbean Region. Brazil’s rates are mid-range, 
although relatively high if considering only South Ameri-
can countries.
Risk factors
Figure 4 shows the contribution, in DALYs, of each dia-
betes risk factor identified by the GBD 2015. High body 
mass index, dietary risks (principally low whole grain 
and low nuts and seeds consumption, and high processed 
meat consumption), and low physical activity were the 
most important risk factors for diabetes.
Table  3 presents the population attributable fractions 
of diabetes DALYs and deaths due to each risk factor, as 
Table 1 Age-specific, and  crude (all ages) and  age-standardized disability-adjusted life year (DALY) rates (/100,000) 
of diabetes mellitus in Brazil compared to the overall world rates, 1990 and 2015
Age group 1990 2015
Global Brazil Global Brazil
Rate 95% UI Rate 95% UI Rate 95% UI Rate 95% UI
Under 5 58.9 (49.0 67.0) 62.8 (55.3 71.6) 22.1 (18.4 24.4) 24.0 (20.0 27.9)
5–9 23.0 (19.9 26.7) 29.7 (24.9 34.8) 15.7 (13.2 19.0) 15.5 (12.4 19.3)
10–14 45.1 (37.2 56.0) 67.1 (54.9 82.0) 38.0 (30.0 49.4) 39.8 (30.3 52.6)
15–19 84.0 (66.2 108.9) 116.0 (94.4 145.0) 91.6 (69.3 119.5) 89.0 (67.6 117.8)
20–24 146.9 (114.1 186.0) 170.7 (136.9 213.7) 168.7 (127.8 219.0) 143.9 (107.9 186.3)
25–29 214.0 (165.3 273.8) 249.8 (201.9 310.2) 256.8 (192.9 333.5) 224.2 (170.2 288.3)
30–34 312.2 (242.9 397.8) 358.0 (292.9 440.9) 384.1 (289.5 499.2) 331.6 (256.0 429.6)
35–39 448.2 (349.4 567.0) 523.8 (434.2 638.6) 565.0 (432.0 722.6) 495.0 (385.6 626.4)
40–44 659.4 (520.7 821.5) 799.0 (666.2 963.0) 830.7 (647.7 1053.6) 765.0 (604.4 958.9)
45–49 1022.3 (827.8 1264.5) 1246.0 (1037.0 1512.3) 1241.7 (983.4 1556.5) 1190.9 (944.3 1490.3)
50–54 1435.9 (1175.5 1747.8) 1892.2 (1591.6 2277.0) 1762.3 (1415.1 2175.0) 1820.5 (1469.0 2260.6)
55–59 1939.8 (1631.4 2336.0) 2694.1 (2292.1 3133.0) 2361.7 (1958.5 2817.1) 2581.4 (2160.5 3110.6)
60–64 2465.1 (2099.2 2906.9) 3533.7 (3072.4 4091.9) 2845.1 (2409.6 3360.3) 3514.3 (2989.2 4149.6)
65–69 2946.5 (2550.2 3462.3) 4356.6 (3836.9 4975.1) 3537.8 (3028.4 4120.4) 4461.8 (3836.4 5169.2)
70–74 3255.2 (2844.5 3752.8) 5178.5 (4684.2 5833.0) 3843.0 (3316.1 4442.0) 5292.1 (4631.1 6052.0)
75–79 3400.7 (2992.7 3889.5) 5702.8 (5189.1 6299.8) 4128.5 (3594.0 4741.4) 5976.1 (5308.4 6806.0)
80 plus 2441.4 (2166.5 2775.3) 4232.3 (3888.4 4643.9) 3185.4 (2826.0 3599.7) 5570.1 (5072.8 6144.9)
All ages (crude) 567.9 (480.5 672.2) 641.4 (558.1 740.8) 870.1 (725.7 1032.6) 1015.3 (865.3 1191.4)
Age‑standardized 769.9 (654.1 907.0) 1094.2 (962.6 1247.7) 925.8 (776.1 1096.3) 1102.8 (948.7 1285.4)
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well as rates of diabetes DALYs and deaths due to these 
risk factors in Brazil in 2015. No significant association 
was found for alcohol use.
Chronic kidney disease related to diabetes
The GBD disease category of CKD due to diabetes mel-
litus permits a specific evaluation of this aspect of the 
diabetes burden. In 2015, 21,519 individuals (95% UI 
19,906–24,481) died from CKD due to diabetes in Bra-
zil. Between 1990 and 2015, crude CKD death rates due 
to diabetes increased from 4.64 (95% UI 4.30–5.37) per 
100,000 to 10.35 (95% UI 9.58–11.78) deaths per 100,000. 
In 2015, the age-standardized death rate of CKD due to 
diabetes was 12.45 per 100,000 (95% UI 11.52–14.08) in 
Brazil, approximately 2 times the global rate of 6.50 per 
100,000 (95% UI 6.06–6.86).
Considering not just deaths but also disability, and 
excluding the effect of population growth, the burden 
of CKD due to diabetes increased more than 50% over 
the period studied, as the crude rate of DALYs increased 
from 158 (95% UI 144–176) per 100,000 in 1990, to 261 
(95% UI 239–298) per 100,000 in 2015. The age-standard-
ized DALY rate per 100,000 was 281 (95% UI 258–320) 
in Brazil in 2015, up 11% from 1990 and almost double 
the overall world rate of 163 (95% UI 150–177). In 2015, 
49.5% of the overall CKD burden was due specifically to 
diabetes in Brazil, up from 38.8% in 1990.
High fasting plasma glucose (HFPG)
As mentioned above, only part of the DALYs resulting 
from diabetes occurs through living with diabetes or suf-
fering its traditional microvascular complications. We 
thus next explored the broader burden which includes 
that attributable via other diseases for which diabetes 
and intermediate hyperglycemia are considered causal, 
identified in GBD 2015 as ischemic heart disease, stroke, 
chronic renal disease and tuberculosis. Figure  5 shows 
the relative size of this burden, when expressed by HFPG, 
in relation to that of other risk factors. In 2015, HFPG 
was the 4th leading cause of overall DALYs in Brazil.
The attributable burden to HFPG was 1441 DALYs per 
100,000 (95% UI 1276–1633) in 1990, which increased by 
35.2% to 1686 DALYs per 100,000 (95% UI 1339–2140) 
in 2015. In 2015, 52.1% of these DALYs arose directly 
from difficulties related to living with diabetes or to suf-
fering direct diabetes complications, as detailed in Fig. 1; 
17.9% from ischemic heart disease; 17.8% from chronic 
kidney disease; 8.6% from hemorrhagic stroke; 0.5% from 
tuberculosis; 2.7% from ischemic stroke; and 0.3% from 
peripheral artery disease (Fig. 6).
HFPG was responsible (PAF) for 65.9% (95% UI 61.0–
71.1) of all CKD DALYs, 18.7% (95% UI 13.0–25.4) of all 
ischemic heart disease DALYs, 10.2% (95% UI 6.7–14.0) 
of all tuberculosis DALYs, 17.6% (95% UI 12.1–24.6) of all 
hemorrhagic stroke DALYs, 17.2% (95% UI 10.3–29.1) of 
all ischemic stroke DALYs, and 26.6% (95% UI 23.7–29.8) 
of all peripheral artery disease DALYs.
DALYs due to HFPG represented 4.1% of all DALYs 
and 8.2% of NCD DALYs in 1990. By 2015, with a total 
of 4,049,510 DALYs estimated to be lost due to diabetes 
or HFPG, these relative burdens had climbed to 7.0 and 
9.8%, respectively.
Discussion
This report, to our knowledge, is the first comprehen-
sive evaluation of the large and growing burden of dia-
betes and HFPG, including CKD, in Brazil. From 1990 to 
2015 Brazil, like most of the world´s countries, witnessed 
major improvements in health, so that, despite popula-
tion aging, the annual crude rate of DALYs, considering 
all diseases, decreased. In stark contrast, DALYs due to 
diabetes and HFPG climbed considerably. As a result, 
the fraction of total DALYs due to diabetes and HFPG 
increased 70%. Given the relatively greater increase in 
YLDs than in YLLs, this burden is now relatively evenly 
Table 2 Decomposition analysis of  the change of  DALYs (thousands) due to  diabetes from  1990 to  2015 as  being due 
to total population growth, population aging, and changes in age-, sex-specific DALY rates of diabetes for Brazil
Value 95% uncertainty 
interval
1990 DALYs (thousands) 965,533 840,159 1,115,075
DALYs expected with 2015 population, 1990 population age structure, 1990 DALY rates (thousands) 1,369,996 1,192,103 1,582,182
DALYs expected with 2015 population, 2015 population age structure, 1990 DALY rates (thousands) 2,065,958 1,775,425 2,416,933
2015 DALYs (thousands) 2,110,242 1,798,473 2,476,379
Percent change from 1990 due to population growth 41.9%
Percent change from 1990 due to population ageing 72.1%
Percent change from 1990 due to change in DALY rates 4.6%
Percent change from 1990 to 2015 (total) 118.6%
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distributed between mortality and morbidity. The burden 
of CKD due to diabetes grew at an even more rapid pace.
The magnitude of Brazil’s diabetes burden places it 
mid-range in the ranking of Latin American countries. 
However, this fact should provide little comfort as the 
Latin American region is particularly affected by the 
combined obesity and diabetes epidemics [7].
The huge burden of diabetes and HFPG in Brazil has 
received less attention than it merits due to several pos-
sible reasons. First, the upward shift in the prevalence 
of self-reported diabetes has never been dramatic from 
one year to the next, rather following a slow but steady 
rise. Second, the prevalence of diabetes, as usually 
reported, for example 6.2% in Brazil’s nationally rep-
resentative sample in 2013 [14], is based on self-report, 
which accounts for only part of the total cases of dia-
betes, since an important fraction of cases are undiag-
nosed. Data from ELSA-Brasil suggest that when a full 
accounting of diabetes is performed, including not only 
self-reported information on a previous diagnosis or 
Fig. 3 Age‑standardized rates of death attributable to diabetes across countries of Latin America and The Caribbean, 2015
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use of anti-diabetic medication but also measurements 
of plasma glucose (at fasting and 2 h post load) and gly-
cated hemoglobin, the prevalence increases by 50–100%, 
depending on the laboratory measurements considered. 
Third, prevalence estimates based on the whole popula-
tion (the GBD approach) or the whole adult population 
(as in VIGITEL and in nationally representative Brazil-
ian surveys) do not adequately illustrate cumulative risk 
across the lifespan, in that few individuals are affected 
during childhood, adolescence and young adulthood. In 
the ELSA-Brasil cohort, the prevalence of diabetes above 
age 60 was over 30% [15]. Thus, the lifetime prevalence in 
ELSA participants, which is probably a low estimate for 
all Brazilians given the relatively high educational level 
of this cohort, is at least 30%. We believe that the recent 
near doubling of self-reported prevalence combined with 
this current estimate of lifetime prevalence provide a bet-
ter vision of the current and probable future size of the 
diabetes epidemic. Fourth, as the complications of dia-
betes usually take years to develop, and the epidemic is 
advancing, the current picture very likely underestimates 
to a large extent the future diabetes burden.
Great attention in Brazil has focused recently on the 
epidemic infectious diseases Zika, dengue and chikungu-
nya. While these diseases are important, and the extent 
of the chronic burden of Zika is yet to be fully known, 
it is hard to imagine that their impact will come close to 
that currently resulting from diabetes. For example, as of 
June, 2016, the Ministry of Health had identified approxi-
mately 1600 cases of microcephaly, most not confirmed 
as being due to Zika [16]. This contrasts with the GBD 
2015 estimates of approximately 12 million Brazilians 
currently having diabetes, over 450,000 new cases of 
diabetes per year, and the staggering total annual loss of 
4,049,510 disability adjusted years of life due to diabetes 
and hyperglycemia.
In 2011, the Brazilian government developed a compre-
hensive strategy to confront the NCDs. Available indica-
tors show that this strategy is in general advancing well in 
terms of risk factor levels, disease prevalence and mor-
tality [17]. The rapidly rising prevalences of obesity and 
diabetes are the glaring exceptions. An additional issue is 
that the problems caused by obesity and diabetes go far 
beyond health. Diabetes, along with other major NCDs, 
has been recognized to impact negatively in a large and 
growing manner on the economic welfare of nations. If 
not adequately addressed, the cost involved in caring for 
diabetes and its complications along with the loss in pro-
ductivity resulting from the disease could significantly 
hinder future economic development [18].
Controlling the diabetes epidemic will require atten-
tion to its causes. Though these causes are not yet com-
pletely understood, the known driving forces, in addition 
to growth and aging of the population, are mainly related 
to the concomitant obesity epidemic. Figure 5 shows that 
a high body mass index to be the 3rd leading risk factor 
for overall disease burden in Brazil.
Our findings thus call for increased efforts to control 
diabetes and its complications especially CKD, through 
adequate health promotion, prevention, early detection, 
and medical care. Obesity and diabetes, like all diseases, 
are socially determined, and as such require not just indi-
vidual actions but socially constructed solutions. Recent 
efforts led by the Ministry of Health in Brazil, such as the 
new nutritional guidelines [19], and efforts at all levels 
of government to stimulate greater physical activity in 
leisure e and in commuting to and from the workplace 
merit support and need to be expanded. As many pre-
vention initiatives with major impact on diabetes rely on 
policies that are implemented outside the health sector, 
e.g. regulation of food products, investments to increase 
access to leisure and physical activities, public safety poli-
cies and taxes on tobacco products, focus on coordinated 
efforts across multiple sectors, such as that which has 
been led by CAISAN in recent years to meet the chal-
lenge of obesity [20, 21], are critical. The presence of sev-
eral factors not traditionally considered as conferring risk 
for diabetes—low consumption of whole grains and seeds 
and nuts, and high consumption of red and processed 
meat—emphasize the importance of incorporating new 
evidence into public health and clinical actions.
Additionally, diabetes is the quintessential life course 
disease, as its risk factors and its underlying patho-
physiology of increased insulin resistance followed by 
decreased insulin secretion have been shown to span 
across the life cycle. In this regard, a nationally repre-
sentative survey of 9th grade Brazilian school children 
showed a greater frequency of intake of sugar sweet-
ened beverages than of fruits, and a greater frequency 
of watching television ≥2 h/day than of participating in 
physical education classes ≥2×/week. Fully 17.8% (17.1–
18.4%) of these adolescents considering themselves to 
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Fig. 4 Risk factors for diabetes, expressed in terms of DALYs attribut‑
able to diabetes. 2015 Brazil
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Fig. 5 Relative importance of high fasting plasma glucose within the context of all risk factors identified by the GBD 2015. Brazil, 2015. WaSH water, 
sanitation and hygiene
Fig. 6 Distribution of disease causes of DALYs attributable to high fasting plasma glucose. Brazil, 2015
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be obese [22]. Additionally, a recent representative sur-
vey conducted in the nation’s capital cities showed that 
only 8% of Brazilian adults aged 18–29 were pursuing a 
healthy lifestyle when that was defined as not smoking, 
undertaking  adequate leisure time physical activity, and 
eating fruits and vegetables at least 5  days a week [23]. 
If healthier lifestyles in childhood and young adulthood 
cannot be stimulated, there is little hope for adequate 
control of obesity and diabetes in later life.
Health care systems, both the public Sistema Único 
de Saúde and those of the private supplementary health 
care sector, must also be adapted, for example, through 
the chronic care model [24], to work effectively to pre-
vent and manage obesity, diabetes, and their compli-
cations. Data from ELSA-Brasil suggest that for every 
individual with diabetes, at least one additional one 
will have intermediate hyperglycemia [15]. The level of 
hyperglycemia of many of these places them at greater 
than 40% risk to progress to diabetes within the next 
decade [25]. Repeated clinical trials have shown dia-
betes can be prevented or at least significantly delayed 
with lifestyle interventions in up to 50% of those with 
impaired glucose tolerance [26]; and that these inter-
ventions can be translated into general practice, though 
with somewhat less effectiveness [27]. In this regard, the 
Family Health Strategy, with its emphasis on team care, 
including community health workers with their special 
role of delivering culturally appropriate health educa-
tion, and its greater presence in socio-economically less 
favored settings where the prevalence and consequences 
of hyperglycemia are greatest, should be a key to con-
fronting the obesity and diabetes epidemics at the level 
of the individual.
Much benefit can also be gained by the adequate treat-
ment of those with diabetes. The evidence base for the pre-
vention of diabetes complications is well established. Within 
these efforts, additional focus needs to be given to the pre-
vention of CKD among those with diabetes. With the major 
increase in prevalence of diabetes, CKD due to diabetes has 
expanded rapidly. Though not all CKD in diabetes is due to 
diabetes, those with diabetes are an easily identifiable sub-
group of adults at greatly increased risk, and effective clini-
cal strategies exist to retard the advance of this disease [28]. 
That rates of DALYs resulting from CKD due to diabetes in 
Brazil in 2013 were approximately twice overall world rates 
emphasizes the gains in avoidable health care costs that 
could be reaped with better prevention of this condition.
The stability in mortality over time shown here, in the 
face of an ever-increasing number of individuals with dia-
betes, means that mortality among those with diabetes is 
declining, probably due in large part to improvements 
in health care over recent decades. As a result, afflicted 
individuals will live longer, which additionally increases 
prevalence and thus adds to the economic burden of the 
disease. In this regard, recent estimates suggest that men 
and women currently with diabetes in the US will live, on 
average, 28 years with their disease [29]. Thus, even if we 
are successful in decreasing the incidence of diabetes and 
death from its complications, prevalence and continued 
disease burden will continue to accrue from the greater 
fraction of the population who will suffer YLDs from dec-
ades of exposure to diabetes-level hyperglycemia.
Strengths of this report stem from the extensive data 
collection and innovative data analysis techniques devel-
oped by the Institute for Health Metrics and Evaluation 
for use in the GBD project. These permit estimations in 
the presence of data that are limited in extent and of less 
than optimum quality.
Aside from the limitations due to uncertainties with 
respect to the prevalence of diabetes and hyperglyce-
mia, rates of progression to and excess mortality from 
complications, and disability weights of diabetes seque-
lae in Brazil, an additional major limitation of this study 
merits discussion. GBD 2015 does not take into account 
the more recently recognized complications of diabetes 
in calculations of DALYs. Approximately 40% of diabe-
tes deaths are now estimated to be non-vascular, with 
diabetic renal disease representing only a small frac-
tion of these deaths. Important non-vascular complica-
tions include liver, pancreas, ovary, colorectal, lung and 
breast cancers; pneumonia and other infections, chronic 
obstructive pulmonary disease, and a broad range of 
other medical conditions [30]. Thus, the overall burden of 
diabetes and intermediate hyperglycemia presented here 
may be seriously underestimated. Finally, we recognize 
the difficulty in using mortality data to characterize dia-
betes burden. The GBD approach, like most, is based on 
underlying cause of death, and diabetes has a strong role 
not only as an underlying cause but also as a contributory 
cause. In this regard, one of the main advantages of the 
GBD approach is the additional analyses of burden based 
on high fasting plasma glucose, which take into account 
the burden of diabetes and intermediate hyperglycemia 
as contributory causes.
Conclusions
In conclusion, diabetes and hyperglycemia in general play 
a large and rapidly growing role in the burden of disease 
in Brazil. Health authorities and society in general would 
do well to pay greater attention to the prevention and 
management of these conditions.
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